IMMY Lateral Flow Aspergillus Galactomannan

Products are for professional/laboratory use only.  Over 30 million people are at risk of invasive aspergillosis each year due to use of corticosteroids, chemotherapy or other immunosuppressive agents, and over 300,000 patients develop it annually. ¹

Timely diagnosis and early initiation of therapy strongly influence outcome for patients at risk of invasive fungal infections.

IMMY Lateral Flow Aspergillus Galactomannan

• Results in 45 minutes
• Storage at room temperature
• Ready to use reagents
• Shelf life 12 months from manufacturing
• Sample type: Serum and Bronchoalveolar lavage (BAL)
• Simplified procedure with minimal specimen preparation

Please check regulatory status in your country.

Reference:

http://www.life-worldwide.org/fungal-diseases/invasive-aspergillosis

Go Back